Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Perspective on the latest trends, issues and opportunities for the commercial real estate market
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Pathfinders Podcast | Research
June 2023
Gregory Renza, M.D., Senior Biotechnology Analyst, delves into the driving forces behind the recent surge of biotech...
Pathfinders Podcast | Investment Banking
RBC’s Noël Brown, Head of US Biotechnology Investment Banking, recently held an Endpoints roundtable with Jerel Davis...
industries in motion
Mark Odendahl, Head of US Capital Markets Research, is joined by Brian Abrahams, Head of Biotechnology at RBC Capital...
markets in motion
Today in the podcast, three big things you need to know: First, we looked at S&P 500 performance when market cap...
Insights
Despite a challenging macroeconomic context affecting transactions during the start of 2023, the US healthcare sector...
Increased regulatory scrutiny is pushing boards towards considering smaller deals, while sizable sponsor balance sheets...
Today in the podcast, part 2 of our US equity market outlook update, we discuss our views on higher level positioning...
May 2023
Today in the podcast, part 1 of our US equity market outlook update, we discuss our revised S&P 500 forecasts and...
Biopharma
In this rebroadcast interview, Dr. Ted W. Love, President and CEO of Global Blood Therapeutics (GBT), discusses how the...
Get the latest insights from RBC Capital Markets delivered to your inbox.